OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11304	Companies
251229	Keywords
180288	Articles
137081	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 07/25/2025 at 18:00, 1 year 3 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 10 obligations convertibles en Oxurion, augmentant le capital de 250 000 EUR. Oxurion reçoit 11 161 618 nouvelles actions pour 250 000 EUR dans le cadre de l'engagement de 20 millions EUR d'Atlas

Innovation Capital Atlas Special Opportunities Oxurion Convertissement
PRESS RELEASE

published on 07/25/2025 at 18:00, 1 year 3 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 10 convertible bonds in Oxurion, resulting in a EUR 250,000 capital increase. Oxurion continues focus on innovative therapeutics for elderly vision preservation

Capital Increase Therapeutics Atlas Special Opportunities Oxurion Vision Preservation
BRIEF

published on 07/24/2025 at 18:05, 1 year 3 months ago

Augmentation du capital d'Oxurion suite à une conversion d'obligations

Capital Biotechnologie Actions Atlas Oxurion
BRIEF

published on 07/24/2025 at 18:05, 1 year 3 months ago

Oxurion capital increase following a bond conversion

Capital Biotechnology Actions Atlas Oxurion
PRESS RELEASE

published on 07/24/2025 at 18:00, 1 year 3 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC converteert 7 obligaties in Oxurion, resulterend in EUR 175.000 kapitaalverhoging. Oxurion richt zich op innovatieve geneesmiddelen voor ouderen

Kapitaalverhoging Oxurion Atlas Special Opportunities, LLC Innovatieve Geneesmiddelen Ouderen
PRESS RELEASE

published on 07/24/2025 at 18:00, 1 year 3 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 7 bonds in Oxurion, leading to EUR 175,000 capital increase. Oxurion focuses on therapeutic innovation to preserve elderly vision

Capital Increase Atlas Special Opportunities Oxurion Therapeutic Innovation Vision Preservation
BRIEF

published on 07/23/2025 at 18:05, 1 year 3 months ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
BRIEF

published on 07/23/2025 at 18:05, 1 year 3 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/23/2025 at 18:00, 1 year 3 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop aandelen. Leuven biofarmaceutisch bedrijf België

Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/23/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding share threshold crossing under Belgian legislation

Transparency Notification Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC Share Threshold

Accesswire

Published on 11/10/2026 at 08:00, 1 hour 55 minutes ago

PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 7 hours 10 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 10 hours 45 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 10 hours 55 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 11 hours 23 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 09:45, 10 minutes ago

TRATON GROUP’s International Motors receives U.S. content approval from U.S. Department of Commerce
Published on 11/10/2026 at 09:30, 25 minutes ago

Original-Research: DN Group AG (von GBC AG): BUY
Published on 11/10/2026 at 09:15, 40 minutes ago

AssureTrace Appoints Graham Clark as Business Director and Chief Revenue Officer
Published on 11/10/2026 at 09:05, 50 minutes ago

Cepheid Achieves CE Marking Under IVDR for Xpert® Respiratory Panel
Published on 11/10/2026 at 09:05, 50 minutes ago

Jackery Black Friday 2026: Up to 58% Off Explorer v2 Portable Power Stations and Solar Generators, Starting at Just £378

Les Echos

Published on 11/10/2026 at 07:00, 2 hours 55 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 2 hours 55 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 15 hours 25 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 15 hours 25 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 16 hours 10 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE